Brief: Indaptus Therapeutics Reports First Quarter 2022 Financial Results
12/05/2022 13:29
May 12 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.41
* ON TRACK TO INITIATE PHASE 1 CLINICAL TRIAL OF DECOY20 FOR
TREATMENT OF SOLID TUMORS IN SECOND HALF OF 2022
* ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND)
APPLICATION FOR DECOY20
* AS OF MARCH 31, 2022, COMPANY HAD CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES OF APPROXIMATELY $36.2 MILLION
Source text for Eikon: ID:nGNX5CzQzR
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))